Pfizer further pares Haleon stake with £2.5 billion sale
(Bloomberg) -- Pfizer Inc. sold about 700 million shares in Haleon Plc, representing a roughly 7.7% stake in the maker of Sensodyne toothpaste.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyAs E-Bikes Boom in NYC, Some Call for More RegulationsA Blueprint for Better Bike LanesThe deal raised around £2.5 billion ($3.1 billion) for the seller, which offered the shares through an accelerated placement with investors, according to terms seen by Bloomberg. The offer